Cancer Research Meeting Calendar  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 1046-1051, March 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krishan, A.
Right arrow Articles by Wellham, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krishan, A.
Right arrow Articles by Wellham, L. L.

Flow Cytometric Studies on Modulation of Cellular Adriamycin Retention by Phenothiazines1

Awtar Krishan2, Antonieta Sauerteig and Larry L. Wellham

Department of Oncology, University of Miami Medical School, and the Comprehensive Cancer Center for the State of Florida, Miami, Florida 33136

Phenothiazines (chlorpromazine and trifluoperazine) enhance the cellular retention and cytotoxicity of Adriamycin in P388/S and P388/R cells. Effects on the resistant cells are more pronounced than those on the sensitive cells. Multiparametric flowcytometric determination of cellular Adriamycin fluorescence shows that the phenothiazine effects are not uniform in a cell population, and cells in later part of the cell cycle traverse (S and G2/M), mitogen-stimulated lymphocytes (as compared to nonstimulated lymphocytes), and ascites (as compared to splenocytes) have greater sensitivity to phenothiazine effects on Adriamycin retention.

1 These studies were supported by NIH Grant CA-23960 from the National Cancer Institute.

2 To whom requests for reprints should be addressed, at Cancer Center, R-71, P. O. Box 016960, Miami, FL 33101.

Received 4/ 9/84. Accepted 11/15/84.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A. Krishan, K. S. Sridhar, C. Mou, W. D. Stein, E. Lyubimov, Y.-P. Hu, and H. Fernandez
Synergistic Effect of Prochlorperazine and Dipyridamole on the Cellular Retention and Cytotoxicity of Doxorubicin
Clin. Cancer Res., April 1, 2000; 6(4): 1508 - 1517.
[Abstract] [Full Text]


Home page
MutagenesisHome page
A.A. Pantazaki and Th.S. Lialiaris
A combined biochemical and cytogenetic study of thioridazine-induced damage to nucleic acids
Mutagenesis, March 1, 1999; 14(2): 243 - 248.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Kobayashi, N. Watanabe, N. Yamauchi, N. Tsuji, T. Sato, and Y. Niitsu
Endogenous Tumor Necrosis Factor as a Predictor of Doxorubicin Sensitivity in Leukemic Patients
Blood, April 1, 1997; 89(7): 2472 - 2479.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.